Opca Bolnica Zadar

The medical center is at the forefront of nephrology research, with a particular focus on IgA Nephropathy. This condition, characterized by the accumulation of IgA antibodies in the kidneys, leads to inflammation and can progress to kidney failure. The center's research aims to evaluate innovative treatments that can significantly alter the course of this disease.

• IgA Nephropathy
• Proteinuria Management
• Renal Inflammation

Through its clinical trials, the center is pioneering new therapeutic approaches that could transform the management of kidney diseases, offering hope for improved patient outcomes.

Specializing in ophthalmology, the center is conducting cutting-edge research on neovascular age-related macular degeneration (nAMD). This condition is a leading cause of vision loss in older adults, and the center's work focuses on comparing the efficacy and safety of novel treatments to existing standards.

• Neovascular Age-Related Macular Degeneration
• Visual Acuity Improvement
• Retinal Health

By advancing treatment options, the center is contributing to the preservation of vision and enhancing the quality of life for patients affected by this debilitating condition.

The center is a leader in oncology research, with a focus on follicular lymphoma. This type of non-Hodgkin lymphoma is characterized by slow growth, and the center's research is dedicated to improving treatment outcomes through innovative combination therapies.

• Follicular Lymphoma
• Combination Immunotherapy
• Hematologic Malignancies

Through its research initiatives, the center is enhancing the understanding of lymphoma treatment, aiming to increase remission rates and improve long-term survival for patients.